Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert T Dess

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|March 10, 2022
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung CancerAlex K Bryant, Huiying Yin, Matthew J Schipper, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2021
Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung CancerMatthew R McFarlane, Kimberly A Hochstedler, Anna M Laucis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2024
Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality ConsortiumMichael P Dykstra, Samuel N Regan, Huiying Maggie Yin, et al.
JCO Oncology Practice|February 15, 2022
Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation TherapyAnna Mary Brown Laucis, Kimberly A Hochstedler, Matthew J Schipper, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
JAMA Oncology|October 29, 2020
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 PandemicHolly E Hartman, Yilun Sun, Theresa P Devasia, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|March 10, 2022
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung CancerAlex K Bryant, Huiying Yin, Matthew J Schipper, et al.
JAMA Network Open|January 11, 2023
Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysisRandy A Vince, Ralph Jiang, Merrick Bank, et al.
BJU International|July 16, 2017
Erectile function after stereotactic body radiotherapy for localized prostate cancerRobert T Dess, Holly E Hartman, Nima Aghdam, et al.
European Urology|December 14, 2020
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)Luca F Valle, Eric J Lehrer, Daniela Markovic, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2021
Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung CancerMatthew R McFarlane, Kimberly A Hochstedler, Anna M Laucis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 16, 2025
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate CancerSean R Miller, Dana H Chung, Rachel T Gonzalez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 6, 2024
Variation in Androgen Deprivation Therapy Use Among Men With Intermediate-Risk Prostate Cancer: Results From a Statewide Radiation Oncology Quality ConsortiumMichael P Dykstra, Samuel N Regan, Huiying Maggie Yin, et al.
JCO Oncology Practice|February 15, 2022
Racial Differences in Treatments and Toxicity in Patients With Non-Small-Cell Lung Cancer Treated With Thoracic Radiation TherapyAnna Mary Brown Laucis, Kimberly A Hochstedler, Matthew J Schipper, et al.
Prostate Cancer and Prostatic Diseases|July 21, 2021
Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborativeRandy A Vince, Ralph Jiang, Ji Qi, et al.
JAMA Oncology|October 29, 2020
Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 PandemicHolly E Hartman, Yilun Sun, Theresa P Devasia, et al.
Pageof 10